AzTrials
AzTrials

AnxietyStSNCT04556331

Sowing the Seeds of Confidence: Brief Online Group Parenting Programme for Anxious Parents of 1-3 Year Olds

A study testing Parenting programme (cognitive behavioural) aimed at reducing generational transmission of anxiety in people with Anxiety and Parenting, run by King's College London at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To pilot a brief group early intervention aimed at reducing or preventing the intergenerational transmission of anxiety, with parents whose child is between 12 and 47 months. To explore feasibility and acceptability of such an intervention with this population. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Anxiety, Parenting
What is being tested?
Parenting programme (cognitive behavioural) aimed at reducing generational transmission of anxiety
How many people
32 participants
Where
1 siteUnited Kingdom
Study dates
25 Sep 2020to 31 Jan 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • current or recent (within 2 years) primary diagnosis of anxiety disorder or self-report of clinically impairing anxiety problem within last 2 years,
  • parent of child aged 12-47 months at time of intervention,
  • access to an internet connection and smart phone/computer will be required to take part,
  • male or female,
  • resident in England,
  • and over the age of 18

Who cannot join

  • current severe co-morbid diagnoses, e.g. psychosis or acute suicidal risk (as the nature of the intervention is brief and in a group, the level of support needed to keep those with severe mental health disorders safe will not be available),
  • current alcohol or drugs misuse

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • South London and Maudsley NHS Trust

    London, SE8

Other trials in United Kingdom

About this study

Official title: Brief Online Group Parenting Programme for Anxious Parents of 1-3 Year Olds With the Aim of Reducing Transmission of Anxiety Through Generations: A Feasibility Study

To pilot a brief group early intervention aimed at reducing or preventing the intergenerational transmission of anxiety, with parents whose child is between 12 and 47 months. To explore feasibility and acceptability of such an intervention with this population.

Read the detailed description

All participants will attend two group sessions of 'psychoeducation' (psychologically informed information about the topic of transmitting anxiety) and cognitive-behavioural strategies aimed at reducing the transmission of anxiety from parent to young child. The two sessions will be delivered online via Microsoft Teams, last 2 hours each and will run one week apart. Outcome and acceptability measures will be collected before, immediately after, and 6 weeks after the intervention. Feasibility data (e.g. drop-out rate) will be recorded.

Conditions
Anxiety, Parenting
Being tested
Parenting programme (cognitive behavioural) aimed at reducing generational transmission of anxiety
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Parenting programme (cognitive behavioural) aimed at reducing generational transmission of anxietyBehavioural

    'Psychoeducation' (psychologically informed information about the topic of transmitting anxiety) and cognitive-behavioural strategies aimed at reducing the transmission of anxiety from parent to young child. These will be shared with a group of maximum 8 remotely delivered, in a didactic format.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants who consented to take part as percentage of those who expressed initial interest.

    Percentage of count (people consent to take part / people expressing interest in response to advertising). To indicate feasibility of larger trial.

    Measured: Total across recruitment period (up to 11 weeks, October 2020 to mid December 2020)

  2. Actual attendance at each session as percentage of expected attendance

    Percentage of count (people scheduled to attend each session / people who actually attended). To indicate feasibility of larger trial.

    Measured: Total across intervention period (up to 9 weeks, mid October 2020 to mid December 2020)

  3. Number of participants who provided completed questionnaire measures

    Percentage of recruited participants who completed questionnaire measures at each of the three collection timepoints.

    Measured: Total across intervention and 6 week follow-up period (up to 15 weeks, mid October 2020 to January 2021)

  4. Acceptability of Intervention Measure (AIM) and Intervention Appropriateness Measure (IAM) (Weiner, Lewis et al. 2017)

    Validated measure of acceptability of an intervention - Acceptability of Intervention Measure (AIM) and Intervention Appropriateness Measure (IAM) (Weiner, Lewis et al. 2017)

    Measured: Collected twice: immediately after intervention attendance (same day) and after 6 weeks.

  5. Open text questions about participants' views on the acceptability

    Open text questions to gather qualitative information about participants' perspectives on usefulness, accessibility and unintended negative consequences

    Measured: Collected twice: immediately after intervention attendance (same day) and after 6 weeks.

Secondary outcomes (3)
  1. Change in score on Brief Infant Toddler Social and Emotional Assessment (Briggs-Gowan, Carter et al. 2002)

    Parent report measure of child social, emotional and behavioural difficulties. This is a 42-item parent-report screening tool validated with parents of children aged 12 to 47 months. Maximum score is 84 and minimum score is 0. The higher the score the worse the outcome.

    Measured: Collected three times to access change: Before intervention, immediately after end of intervention (same day) and 6 weeks after.

  2. Change in score on Depression Anxiety Stress Scale (Henry and Crawford 2005)

    Parent report questionnaire measure of stress, anxiety and depression in parents. This is a 21-item scale. The minimum score is 0 and the maximum score is 63, higher score is a worse outcome.

    Measured: Collected three times to access change: Before intervention, immediately after end of intervention (same day) and 6 weeks after.

  3. Bespoke questionnaire about self-reported use and confidence in behaviours specifically targeted in intervention.

    Bespoke questionnaire about 8 specific parenting behaviours targeted in the intervention, each rated on a 5-point Likert scale (4 are reverse scored). Minimum score is 0 and maximum score is 40. The higher the score the 'worse' the outcome.

    Measured: Collected three times to access change: Before intervention, immediately after end of intervention (same day) and 6 weeks after.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2020
  2. Study start25 Sep 2020
  3. Primary completion20 Jan 2021
  4. Study completion31 Jan 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04556331
Sponsor's protocol ID
19/LO/1438 v7 01062020
Acronym
StS
Status last verified
Sep 2020
First submitted
7 Sep 2020
Last updated
18 Feb 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Palmer E, Woolgar M, Carter B, Cartwright-Hatton S, Challacombe FL. Preventing anxiety in the children of anxious parents - feasibility of a brief, online, group intervention for parents of one- to three-year-olds. Child Adolesc Ment Health. 2023 Feb;28(1):33-41. doi: 10.1111/camh.12596. Epub 2022 Aug 18.

    PubMed 35983606

Questions about this trial

What is this clinical trial studying?

A study testing Parenting programme (cognitive behavioural) aimed at reducing generational transmission of anxiety in people with Anxiety and Parenting, run by King's College London at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants who consented to take part as percentage of those who expressed initial interest. (time frame: Total across recruitment period (up to 11 weeks, October 2020 to mid December 2020)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04556331, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in